Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2002;100:1096-1097
© 2002 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carson, M. P.
Right arrow Articles by Scorza, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carson, M. P.
Right arrow Articles by Scorza, W. E.

CASE REPORTS

Atrial Fibrillation in Pregnancy Associated With Oral Terbutaline

Michael P. Carson, MD, Allan J. Fisher, MD and William E. Scorza, MD

Departments of Medicine and Obstetrics, Gynecology & Reproductive Sciences, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey; and the Division of General Internal Medicine, St. Peter’s University Hospital, New Brunswick, New Jersey

Address reprint requests to: Michael Carson, MD, Saint Peter’s University Hospital, 254 Easton Avenue/CARES Building, 4thFloor, New Brunswick, NJ08903; E-mail: mcarson{at}docisp.com.

ABSTRACT

BACKGROUND: Terbutaline has direct effects on the cardiac conduction system, but when used to treat preterm labor it is rarely associated with clinically significant cardiac arrhythmias. Commonly used drug references did not list atrial fibrillation as a complication of terbutaline, and our literature search found only one case of atrial fibrillation that occurred with parenteral administration.

CASE: A 30-year-old gravida 1 carrying a twin gestation at 35 weeks was taking 2.5 mg oral terbutaline four times daily for premature labor. She developed atrial fibrillation and was ultimately treated by chemical cardioversion with procainamide to restore normal sinus rhythm.

CONCLUSION: This is the first report of atrial fibrillation during pregnancy associated with oral terbutaline. Atrial fibrillation should be added as a complication of oral terbutaline therapy.




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
C. S. van der Hooft, J. Heeringa, G. van Herpen, J. A. Kors, J. H. Kingma, and B. H. Ch. Stricker
Drug-induced atrial fibrillation
J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2117 - 2124.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
S. Lashgari, A. S. Kueck, and Y. Oyelese
Atrial Fibrillation in Pregnancy Associated With Oral Terbutaline Therapy
Obstet. Gynecol., April 1, 2003; 101(4): 814 - 814.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Obstetricians and Gynecologists.